Skip to main content
. 2012 Jan 4;18(1):379–388. doi: 10.2119/molmed.2011.00449

Table 2.

Distribution of SOCS-3 and CXCR2 expression per histological grade in patients with astrocytomas.

Grade II Grade III Grade IV Total
SOCS-3 (%) 3.5 (0–70) 1.75 (0–70) 30 (0–95) 20 (0–95)
CXCR2 (%) 0 (0–5) 0.25 (0–5) 0.5 (0–70) 0 (0–70)

Data are medians (range).